CClinicalTrials.gg
CompletedNCT07068672KHALPAINUpdated Jul 18, 2025

Kaleidoscope and Helicone for Pain and Anxiety in Children

An interventional study of Kaleidoscope and Helicone in Pain Management, Procedural Pain and Children, sponsored by AYLİN ARIKAN. Completed at 1 site in Turkey (Türkiye). Open to participants aged 6 Years to 12 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-07-18.

Sponsored by AYLİN ARIKAN · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 3 months after the study started (first participant enrolled Apr 2025, registered Jul 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
210
Allocation
Randomized
Ages
6 Years to 12 Years
Sex
All
01

Study summary

This randomized controlled trial aimed to evaluate the effects of kaleidoscope and helicone distraction tools on pain and anxiety levels during venipuncture in school-age children. The study was conducted at Ankara Etlik City Hospital Pediatric Emergency Department between April and May 2025. A total of 210 children aged 6 to 12 years who were undergoing venous blood sampling for the first time were randomly assigned to one of three groups: Kaleidoscope, Helicone, or Control (standard care). The Kaleidoscope group used a passive distraction tool featuring dynamic visual patterns; the Helicone group used an active distraction tool that involves hand manipulation of a rotating toy. Pain levels were measured using the Wong-Baker FACES Pain Rating Scale, and anxiety levels were assessed using the Children's Anxiety Meter-State (CAM-S). Measurements were taken before, during, and after the procedure. This study seeks to determine the comparative effectiveness of active versus passive distraction techniques in pediatric procedural pain and anxiety management. All interventions were non-pharmacological, non-invasive, and conducted in a safe clinical setting with informed consent obtained from both children and their guardians.

02

Conditions studied

  • Pain Management
  • Procedural Pain
  • Children
  • Pediatric Nursing

Keywords

  • Kaleidoscope
  • Helicone
  • Pediatric Pain Management
  • School-Age Children
  • Venipuncture
03

In context

Agnosia

1,190 studies on the registry are indexed under Agnosia; 508 are open to participants now.

This study's enrollment of 210 is above the median of 78 across 1,024 interventional studies indexed under Agnosia.

Browse Agnosia studies →

Lead sponsor

This is the only study on the registry with AYLİN ARIKAN as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
6 Years to 12 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Children aged between 6 and 12 years
  • Requiring venipuncture for clinical purposes
  • Able to verbally communicate pain and anxiety
  • Accompanied by a parent or legal guardian who provides written informed consent
  • Child provides verbal assent to participate

Exclusion criteria

Exclusion Criteria:

  • Children with cognitive or neurological disorders affecting pain or anxiety perception
  • Use of any analgesics, anxiolytics, or sedatives within 6 hours prior to the procedure
  • Visual or hearing impairments that interfere with the use of kaleidoscope or helicone
  • Previous experience with similar distraction tools
  • Presence of any skin condition preventing pain scale assessment
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
210 participants (actual)

Study arms

  • Experimental
    Kaleidoscope Group

    Children in this group were provided with a handheld kaleidoscope starting 2 minutes before and during venipuncture. The visual distraction created by the kaleidoscope's changing colorful patterns aimed to reduce pain and anxiety. The child focused on the visual display throughout the procedure.

    Behavioral: Kaleidoscope

  • Experimental
    Helicone Group

    Children in this group used a helicone toy starting 2 minutes before and during venipuncture. The toy, which changes shape with hand manipulation, provided active distraction to reduce pain and anxiety by engaging both visual and tactile senses.

    Behavioral: Helicone

  • No intervention
    Control Group

    Children in this group received standard care during venipuncture without any distraction tools. No visual or tactile distraction was provided.

Interventions

  • BehavioralKaleidoscope

    A handheld kaleidoscope was used as a passive distraction tool during venipuncture. The device was introduced to the child 2 minutes before the procedure and remained in view during blood collection. It provided dynamic, colorful visual stimuli to help reduce pain and anxiety.

  • BehavioralHelicone

    A helicone toy was used as an active distraction tool. Children held and rotated the device beginning 2 minutes before and during venipuncture. The interactive movement and shape-shifting design engaged the child's attention to reduce procedural pain and anxiety.

06

What researchers measure

Primary outcomes

  1. Pain level measured using Wong-Baker FACES Pain Scale

    Pain was assessed by the child using the Wong-Baker FACES Pain Rating Scale. This scale ranges from 0 to 10, where higher scores indicate more severe pain. Evaluations were conducted at three time points: before the procedure, during needle insertion, and two minutes after.

    Time frame: Two minutes before the procedure, during needle insertion, and two minutes after the procedure

  2. Anxiety level measured using Children's Anxiety Meter - State (CAM-S)

    Anxiety was evaluated using the Children's Anxiety Meter - State (CAM-S) tool. The scale ranges from 0 (no anxiety) to 10 (extreme anxiety). Assessments were completed by the child with assistance from the researcher at three time points: before, during, and after the venipuncture.

    Time frame: Two minutes before the procedure, during needle insertion, and two minutes after the procedure

07

Study locations

1 site
  • Ankara Etlik City Hospital
    Ankara, Etlik 06270, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 18, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07068672
Lead sponsor
AYLİN ARIKAN
Responsible party
AYLİN ARIKAN (Doctor of Philosophy in Pediatric Nursing, Ankara University) — Sponsor-investigator
First posted
Jul 16, 2025
Start date
Apr 1, 2025
Primary completion
May 31, 2025
Completion
May 31, 2025
Last update
Jul 18, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion